Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in our Department working on Motor Neuron Disease (MND) do the Ice Bucket Challenge, which has taken the internet by storm this week and so far raised £6 million.

The team wanted to do their bit to raise money for research into this devastating disease. From left to right they are: Lucy Farrimond, David Gordon, Louisa Kent, Jakub Scaber, Kevin Talbot, Martin Turner and Thomas Vizard. 

It was great to take part in the Ice Bucket Challenge. It raises awareness for a devastating disease and I hope people will continue to donate to help us find a cure for Motor Neuron Disease. - Professor Kevin Talbot

MND is a rapidly progressive and fatal disease, which can affect any adult at any time and attacks the motor neurones that send messages from the brain to the muscles, leaving people unable to walk, talk or feed themselves.

The cause of the disease is currently unknown and there is no known cure. Around 5,000 people in the UK have MND at any one time, with half of people with the disease dying within 14 months of diagnosis. It kills five people every day in the UK.

Research in the Oxford Motor Neuron Disease Centre aims to improve understanding of motor neuron diseases, principally amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), to find treatments to improve the lives of patients with these currently incurable conditions.

The Motor Neurone Disease (MND) Association  funds research to understand what causes MND, how to diagnose it and, most importantly, how to effectively treat it so that it no longer devastates lives.

Denise Davies, Head of Community Fundraising at the MND Association, said: “Without the amazing support of people who contribute, the Association simply would not be able to provide its vital support services and fund research to find a cure. Together we are making a real difference for people affected by this devastating disease.”

Donate by visiting www.mndassociation.org or text ICED55 (with amount of your donation)

Similar stories

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.